4.5 Article

AutoGrow 3.0: An improved algorithm for chemically tractable, semi-automated protein inhibitor design

Journal

JOURNAL OF MOLECULAR GRAPHICS & MODELLING
Volume 44, Issue -, Pages 104-112

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jmgm.2013.05.006

Keywords

Drug design; Click chemistry; Autogrow; Computational chemistry

Funding

  1. NIH [GM31749]
  2. NSF [MCB-1020765]
  3. Howard Hughes Medical Institute
  4. NSF Supercomputer Centers
  5. San Diego Supercomputer Center
  6. W.M. Keck Foundation
  7. National Biomedical Computational Resource
  8. Center for Theoretical Biological Physics
  9. [MCA93S013]
  10. Direct For Mathematical & Physical Scien
  11. Division Of Physics [1308264] Funding Source: National Science Foundation

Ask authors/readers for more resources

We here present an improved version of AutoGrow (version 3.0), an evolutionary algorithm that works in conjunction with existing open-source software to automatically optimize candidate ligands for predicted binding affinity and other druglike properties. Though no substitute for the medicinal chemist, AutoGrow 3.0, unlike its predecessors, attempts to introduce some chemical intuition into the automated optimization process. AutoGrow 3.0 uses the rules of click chemistry to guide optimization, greatly enhancing synthesizability. Additionally, the program discards any growing ligand whose physical and chemical properties are not druglike. By carefully crafting chemically feasible druglike molecules, we hope that AutoGrow 3.0 will help supplement the chemist's efforts. To demonstrate the utility of the program, we use AutoGrow 3.0 to generate predicted inhibitors of three important drug targets: Trypanosoma brucei RNA editing ligase 1, peroxisome proliferator-activated receptor gamma, and dihydrofolate reductase. In all cases, AutoGrow generates druglike molecules with high predicted binding affinities. AutoGrow 3.0 is available free of charge (http://autogrow.ucsd.edu) under the terms of the GNU General Public License and has been tested on Linux and Mac OS X. (C) 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available